Investigation of toxin genes of clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University hospital;Marmara Üniversitesi Hastanesinde Yatan Ishalli Hastalardan i·zole Edilen Clostridium difficile Kökenlerinde Toksin Genlerinin Ara̧tinlmasi

Mikrobiyoloji Bulteni

Volumn 45, Issue 1, 2011, Pages 1-10

  Denizl, Umut ^a   Ülger, Nurver ^a   Aksu, Burak ^a   Karavuş, Melda ^b   Söyletir, Güner ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Binary toxin; Clostridium difficile; Toxin a; Toxin b; Turkey

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; BETA LACTAM; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; CHILD; CLOSTRIDIUM DIFFICILE; DIARRHEA; FECES; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PRESCHOOL CHILD; PSEUDOMEMBRANOUS COLITIS; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; BACTERIAL PROTEINS; BACTERIAL TOXINS; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FECES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; TURKEY; YOUNG ADULT;

EID: 79952162020     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C.difficile infection. Clin Infect Dis 2008; 46(Suppl1):S4-11.
2. Pearson A. Historical and changing epidemiology of healthcare-associated infections. ) Hosp Infect 2009; 73(4): 296-304.
3. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136(6): 1913-24.
4. Poxton IR, McCoubrey J, Blair G. The pathogenicity of Clostridium difficile. Clin Microbiol Infect 2001; 7(8): 421-7. (Pubitemid 34960333)
5. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56(9): 2299-306.
6. Summanen P, Baron EJ, Citron DM, Wexler HM, Finegold SM (eds), Laboratory tests for diagnosis of Clostridium difficile enteric disease, pp: 133-41. In: Wadsworth Anaerobic Bacteriology Manual. 1993, 5th ed. Star Publishing Company, California, USA.
7. Yücesoy M, McCoubrey J, Brown R, Poxton RI. Detection of toxin production in Clostridium difficile strains by three different metods. Clin Microbiol Infect 2002; 8(7): 413-8. (Pubitemid 34993818)
8. Kato H, Kato N, Watanabe K, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998; 36(8): 2178-82. (Pubitemid 28324061)
9. Kato N, Ou CY, Kato H, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. I Clin Microbiol 1991; 29(1): 33-7.
10. Stubbs S, Rupnik M, Gibert M, et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000; 186(2): 307-12. (Pubitemid 30232760)
11. Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in Clostridium difficile-associated disease: past and present perspectives. Gut Microbes 2010; 1(1): 58-64.
12. Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12(Suppl 6): 2-18.
13. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infect Control Hosp Epidemiol 2010; 31(9): 939-47.
14. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-reiated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13(9): 1417-19.
15. Soyletir G, Eskiturk A, Kilic G, Körten V, Tozun N. Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in Turkey. Eur J Epidemiol 1996; 12(4): 391-4. (Pubitemid 26302721)
16. Urban E, Tusnadi A, Terhes G, Nagy E. Prevalence of gastrointestinal disease caused by Clostridium difficile in a university hospital in Hungary. J Hosp Infect 2002; 51(3): 175-8. (Pubitemid 38001888)
17. Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47(1): 43-50. (Pubitemid 32058754)
18. Ercis S, Ergin A, Hascelik G. Six years evaluation of Clostridium difficile associated diarrhea. Mikrobiyol Bul 2004; 38(1-2): 45-50.
19. Altindis M, Usluer S, Ciftci H, Tunc N, Cetinkaya Z, Aktepe OC. Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods. Mikrobiyol Bul 2007; 41(1): 29-37.
20. Barbut F, Petit JC. Epidemiology of Clostridium difficile associated infections. Clin Microbiol Infect 2001 ; 7(8): 405-10. (Pubitemid 34960330)
21. Buchner AM, Sonnenberg A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am ) Gastroenterol 2001; 96(3): 766-72. (Pubitemid 32240728)
22. Wroblewska MM, Swoboda-Kopec E, Rokosz A, Nurzynska G, Bednarska A, Luczak M. Detection of Clostridium difficile and its toxin A (tcdA) in stool specimens from hospitalised patients. Pol J Microbiol 2005; 54(2): 111-5. (Pubitemid 41039235)
23. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122(6): 1266-70.
24. Alfa MJ, Swan B, VanDekerkhove B, Pang P, Harding GK. The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C.difficile panel, EIA for Tox A/B and cytotoxin assays. Diagn Microbiol Infect Dis 2002; 43(4): 257-63. (Pubitemid 34874766)
25. Bouza E, Pelaez T, Alonso R, Catalan P, Munoz P, Creixems RM. "Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect 2001; 48(3): 233-7. (Pubitemid 32680863)
26. Rupnik M. How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 2001; 7(8): 417-20. (Pubitemid 34960332)
27. Pituch H, Rupnik M, Obuch-Woszczatynski P, Grubesic A, Meisel-Mikolajczyk F, Luczak M. Detection of binary-toxin genes (cdt A and cdt B) among Clostridium difficile strains isolated from patients with C.difficileassociated diarrhoea (CDAD) in Poland. J Med Microbiol 2005; 54(Pt 2): 143-7. (Pubitemid 40867998)
28. Gonçalves C, Derce D, Barbut F, Burghoffer B, Petit JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 2004; 42(5): 1933-9. (Pubitemid 38637804)
29. Barbut F, Mastrantonio P, Delme M, Brazier J, Kuijper E, Poxton I; European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13(11): 1048-57.